• Go to navigation
  • Go to content
AstraZeneca Clinical Trials

Astrazeneca Worldwide

  • AstraZeneca Websites
AstraZeneca US

Main navigation

  • Home
  • Therapy Areas
    • Oncology/Infection
    • Cardiovascular
    • Gastrointestinal
    • Neuroscience
    • Respiratory/Inflammation
  • Drug Products
    • All Drug Products
  • Diseases & Conditions
    • All Diseases and Conditions
  • Glossary
  • Contact Us
  • Disclosure Commitment

You are here

  • Home
  • Total number of clinical trials
  • Clinical study assessing the safety, tolerability, and pharmacokinetics of intravenous AZD5099 in health subjects

Disease
infection
Drug Name
AZD5099
Generic Name
AZD5099
Sponsor
AstraZeneca
Drug Status
In Development
Phase
I
Start Date
May 27, 2011
Study Name
D0910C00015
Study Id
D0910C00015
ClinicalTrials.gov ID
NCT01340183
Recruiting Status
Open
Protocol Status
Not Available
Report
Jun 18, 2012
  • D0910C00015.pdf (143 KB)

Page tools

  • Print
  • Bookmark this page

Legal notices

  • Legal notice
  • Privacy policy
  • © AstraZeneca 2013